CALYXHA develops novel small-molecule anti-inflammatory drugs
MAG – Molecular Architecture Group – brings together scientists with decades-long experience in NMR applications for drug design
The name says it all: Open Science - Life Sciences in Dialogue is all about making life sciences available to everyone. The association works in a wide variety of communication projects – from discussions to laboratory workshops, teacher training and citizen science projects – to stimulate discussion about life science topics and bring scientists together with school pupils, teachers and anyone else interested in learning more.
We are Experts at Translating Complex Science Into the Real-World: bridge the gap between science and people, manufacturers and regulators. At BioSciPons we work at the interface of regulatory, medical affairs and communication. We are experts at translating complex science into precise and clear communication contents (e.g., Reports, Technical files, Investigator Brochures, Medical Manuscripts, Articles, Instructions for Use, User Manuals, Video Scripts, Posters,...). Our aim is to explain the relevance and ramifications of your medical device or your scientific findings, while maintaining regulatory correctness and scientific acumen. We want to bridge the gap between R&D, regulatory agencies, healthcare and users/consumers - hence our bridge as a logo. To cross this bridge two things are needed: a high level of communication, and a deep understanding of clinical science & regulations. As clinical scientists, we understand the details. As communicators, we can transform your complex clinical data and translate it into a consistent message, that can then be tailored to each target audience (e.g., regulators, peer-reviewers, board executives, users/consumers/patients). With our "outside-of-the-box" approach, we can foresight the gaps in your clinical data; and prepare your product for the "curve ahead". We not only want you to cross the bridge, but help you go forward on a straight highway. BioSciPons works from any starting point for a customised service. We personalise our services to fit the needs of each individual medical/biotechnology product through PhD knowledge.
Expertise: Digital Therapeutics, Artificial Intelligence and Machine Learning Software as Medical Device, Injectables/Implantable's Class III.
Marinomed Biotech AG is a biopharmaceutical company focused on inventing, developing, and partnering clinically meaningful therapies for patients suffering from serious viral infectious diseases and autoreactive immune disorders. Since its foundation in 2006, Marinomed has launched two powerful technologies (Carragelose® and Marinosolv®) with promising product candidates in the pipeline and a great potential for developing drugs that target diseases with high unmet medical need.
BioPeak offers technology consulting for biotech and pharma. BioPeak services include data strategy, data architecture and data analysis solutions, tailored software solutions for your business processes, consultation in bioimaging solutions and hardware engineering for your R&D needs.
Festo – das Unternehmen
Festo Österreich ist Marktführer in der Automation mit Pneumatik und Elektrik sowie der technischen Aus- und Weiterbildung. Das Unternehmen ist für den Vertrieb in Österreich zuständig und bildet zusätzlich die Drehscheibe für die mittel- und osteuropäischen Konzernaktivitäten sowie für die Produkt- und Systementwicklung. Zu Festo Österreich gehören 120 Mitarbeiterinnen und Mitarbeiter – insgesamt beschäftigt Festo in 60 Ländern etwa 20.800 Personen. Mit rund 33.000 Katalogprodukten in einigen hunderttausend Varianten nimmt Festo weltweit eine führende Rolle in der Industrie- und Prozessautomation ein. Jährlich investiert der Konzern rund 7 % seines Umsatzes (2022 rd. 3,81 Mrd. Euro) in Entwicklung und Forschung. In Österreich betreibt Festo eine eigene Forschungseinheit für industrielle Steuerungstechnik und ein Technic and Application Center, das Kunden bei ihrer Entwicklungstätigkeit unterstützt. Corporate Educational Responsibility: Das Familienunternehmen nimmt seine gesellschaftliche Verantwortung vor allem im Bildungsbereich sehr engagiert wahr – beispielsweise durch einen eigenen Bildungsfonds und die Vergabe von Experimentierboxen an Schulen.
www.festo.at
LISAvienna is the cluster platform for life sciences in Vienna, which was set up at the interface of Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Labour and Economy and the City of Vienna, it contributes to the further development of the industry. LISAvienna supports innovative companies in the fields of biotechnology, pharmaceuticals, medical products and digital health that develop new products, services and processes in Vienna and bring them to market internationally. The platform connects these companies with development partners and lead customers. As a thought leader, LISAvienna provides a basis for decision-making to strengthen the life sciences in Vienna and helps to position Vienna as one of Europe's leading innovation centers.
AURIMOD is a commercial stage medical device company founded to disrupt global healthcare by patient-tailored electroceutical pain therapies. We develop products for the minimal-invasive electrical stimulation of the auricular branch of the vagus nerve. By this autonomic stimulation we harness the bodies’ own mechanisms to fight the disease sustainably with a clinically proven effect.
Holloid provides devices and cloud-based software for automated high-throughput holographic microsopcy. It enables users to image, and categorize microorganisms (bacteria, mammalian cells, yeast cells, micro algae) and microparticles (microplastics, etc.) and count them to monitor their presence and growth 24/7.
With this technology, organizations can accelerate research, optimize processes and issue very early warnings about contaminations. This is valuable in in research, development and production. Quality and bioprocess control in red, white and green biotechnology can benefit from unprecedented insights, automated analysis, 1,000 faster reliable insights, 1,000,000 higher throughput. This helps create better medication and products sooner, and accelerate the transition to more sustainable value chains across industries.
lablife gmbh is specialized in the development and production of video tutorials for life science laboratories.
lablife gmbh also offers video tutorials and training material for cell culture laboratories in order to improve reproducibility and standardization of results according to international guidelines for Good Cell Culture Practice (GCCP). The videos tutorials cover important basic skills of the cell culture laboratory, such as good practices, tips and hacks and common mistakes. Protocols and checklists for laboratory work can also be downloaded from the lablife gmbh website. There is also a community area for subscribers for asking questions and sharing knowledge.
Austria Wirtschaftsservice GmbH (aws) is the promotional bank of the Austrian federal government. It supports companies in implementing their innovative projects by offering soft loans, grants and guarantees, particularly in cases where the funds required cannot be obtained sufficiently through alternative funding. LISA - Life Science Austria run by Austria Wirtschaftsservice aims at positioning Austria as a leading life science location offering a variety of support measures. Organized through regional life science clusters, LISA represents companies in the therapeutic, medical technology and diagnostic sectors as well as providers of enabling technologies and related service companies located in the following regions: ecoplus (Lower Austria), Medical Technology Cluster (Upper Austria), LISAvienna (Vienna), human.technology.styria (Styria), Standortagentur Tirol (Tyrol), Innovation Salzburg (Salzburg).
Serviceprovider for pharmaceutical industry, quality management (ISO9001, ISO13485, ISO15224, ISO14971), non-interventional studies, data privacy (GDPR), validation, qualification
We help ambitious clients with scaling and growth through digital success.